Zeidan Ryan 4
4 · Millendo Therapeutics, Inc. · Filed Feb 4, 2020
Insider Transaction Report
Form 4
Zeidan Ryan
Chief Development Officer
Transactions
- Award
Employee Stock Option (right to buy)
2020-01-31+41,250→ 41,250 totalExercise: $7.94Exp: 2030-01-30→ Common Stock (41,250 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the shares subject to this option shall vest on January 7, 2021, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.